Skip to main content
Partner IL

Chief Scientist Office, Ministry of Health

CSO-MOH
← Back to partners Visit organisation website

Programme phases

4

Funding participation

Joint calls funded by this organisation.

11
JTC 2026
2026
JTC 2023
2023
JTC 2022
2022
JTC 2021
2021
JTC 2017
2017
JTC 2016
2016
JTC 2015
2015
JTC 2014
2014
JTC 2013
2013
JTC 2012
2012
JTC 2011
2011

Funded projects

Projects linked to this funding organisation.

23
ATRTPepVac

Exploiting the peptidome of atypical teratoid/rhabdoid tumors - characterization of novel tumor-associated antigens for immunotherapy in order to maintain long-term remissions

JTC 2013
View project
BREMIR

MicroRNAs methylation and expression profiling for identification of breast cancer patients at high risk to develop distant metastases

JTC 2013
View project
CEVIR

Cancer evolution and identification of relapse-initiating cells.

JTC 2014
View project
EpiNanSarc

Sarcoma subtyping and stratification using genome-wide epigenetic profiling

JTC 2023
View project
EPIPROPER

Identifying EPIgenetic determinants and biomarkers of drug resistance via characterization of PROspective PERsister cells

JTC 2023
View project
EXPLORE-NB

Exploring the epigenetic neuroblastoma landscape to improve measurable disease monitoring, disease understanding and personalized treatment

JTC 2023
View project
HLALOSS

New technologies for early detection of HLA loss leukemia relapse after allogeneic hematopoietic stem cell transplantation, and identification of relevant risk factors

JTC 2012
View project
ImmuMet

Invigorating immunity against brain metastases in lung and breast cancer patients

JTC 2021
View project
IntraMMclo

Multiple myeloma intra-clonal heterogeneity: evolution and implications of targeted therapy

JTC 2014
View project
Ma.Tr.OC

Identification of molecular therapeutic targets and diagnostic/prognostic biomarkers for Malignant Transformation of Osteochondromas

JTC 2012
View project
MesaCapp

Mesalamine for Colorectal Cancer Prevention Program in Lynch syndrome

JTC 2012
View project
PANC-P53

Innovative peptide- and RNA-based strategies to modulate p53 for pancreatic cancer therapy

JTC 2022
View project
PREDICT

Personalized prevention of colorectal neoplasia by use of genetic variability for the prediction of efficacy and toxicity of treatment with COX-2 inhibitors and aspirin

JTC 2012
View project
PROMETOV

Proteogenomic and targeted metabolomic analysis of ovarian cancer heterogeneity and its contribution to recurrence and therapy resistance.

JTC 2014
View project
RE-VOLU-TION

pREdiction of niVOLUmab acTION in metastatic renal cancer patients: Treg function, tumoral access and NK interactions as predictive biomarkers of immunotherapy.

JTC 2015
View project
REACTION

Deciphering Epigenetic Biomarkers to Identify Preleukemic Carriers at Risk

JTC 2023
View project
RISEBrain

Reverting immune suppression to elicit brain metastasis control

JTC 2021
View project
SIMMBAP

Systemic immunological determinants of tumor evolution and therapy response in BRCA-mutated pancreatic cancer

JTC 2022
View project
TANGERINE

Artificial-intelligence-based end-to-end prediction of cancer immunotherapy response

JTC 2021
View project
TRANSCALL

Validation of the impact of genetic aberrations and host genetic variation in childhood acute lymphoblastic leukemia for integration into clinical practice

JTC 2011
View project
TRANSCALL-2

Integration of genetic biomarkers and early Minimal Residual Disease to improve risk stratification and cure in childhood Acute Lymphoblastic Leukemia

JTC 2016
View project
TumorOUT

Innovative mRNA vaccine against NSCLC: Designing a platform of targeted polymeric nanoparticles for efficient personalized therapy

JTC 2021
View project